Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phibro Animal Health (PAHC)
NASDAQ:PAHC
Phibro Animal Health (PAHC) Stock Price & Analysis
57 Followers
PAHC Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$9.21 - $18.61
Previous Close$18.4
Volume194.32K
Average Volume (3M)151.78K
Market Cap
$745.27M
Enterprise Value$1.13B
Total Cash (Recent Filing)$92.49M
Total Debt (Recent Filing)$474.90M
Price to Earnings (P/E)56.6
Beta0.82
Next Earnings
Aug 28, 2024EPS Estimate
$0.33Next Dividend Ex-Date
Jun 05, 2024Dividend Yield2.61%
Share Statistics
EPS (TTM)0.32
Shares Outstanding40,503,608
10 Day Avg. Volume147,564
30 Day Avg. Volume151,782
Standard Deviation0.11
R-Squared0.09
Alpha-0.00988
Financial Highlights & Ratios
Price to Book (P/B)4.41
Price to Sales (P/S)1.47
Price to Cash Flow (P/CF)5.80
P/FCF Ratio8.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.15
Enterprise Value/Gross Profit3.78
Enterprise Value/Ebitda12.24
Forecast
1Y Price Target
$16.00Price Target Upside-13.04% Downside
Rating ConsensusModerate Sell
Number of Analyst Covering2
Phibro Animal Health News
PremiumCompany Announcements
Phibro Animal Health Expands Portfolio with Zoetis Acquisition
Bulls Say, Bears Say
Bulls Say
Acquisition SynergyThe on-track acquisition of ZTS' MFA Business is poised to contribute to growth, signifying expansion and synergy potential.
Financial PerformanceRevenue beat consensus by a significant margin, highlighting the company's strong financial performance and market demand.
Strategic GrowthInvesting in high-growth areas such as Vaccines, Companion Animal, and Nutrition showcases the company's strategic focus on promising sectors.
Bears Say
Profitability ConcernAdjusted Gross margins decreased by 40 basis points year-over-year.
Revenue DeclineNutritional Specialties experienced a decline in demand leading to a reduction in revenue.
Sales PerformancePerformance Products sales missed estimates, declining by 4%.
---
Ownership Overview
9.18%
Insiders
25.08% Mutual Funds
58.97% Other Institutional Investors
6.77% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PAHC FAQ
What was Phibro Animal Health’s price range in the past 12 months?
Phibro Animal Health lowest stock price was $9.21 and its highest was $18.61 in the past 12 months.
What is Phibro Animal Health’s market cap?
Currently, no data Available
When is Phibro Animal Health’s upcoming earnings report date?
Phibro Animal Health’s upcoming earnings report date is Aug 28, 2024 which is in 101 days.
How were Phibro Animal Health’s earnings last quarter?
Phibro Animal Health released its earnings results on May 08, 2024. The company reported $0.31 earnings per share for the quarter, beating the consensus estimate of $0.29 by $0.02.
Is Phibro Animal Health overvalued?
According to Wall Street analysts Phibro Animal Health’s price is currently Overvalued.
Does Phibro Animal Health pay dividends?
Phibro Animal Health pays a Quarterly dividend of $0.12 which represents an annual dividend yield of 2.61%. See more information on Phibro Animal Health dividends here
What is Phibro Animal Health’s EPS estimate?
Phibro Animal Health’s EPS estimate is $0.33.
How many shares outstanding does Phibro Animal Health have?
Phibro Animal Health has 20,337,574 shares outstanding.
What happened to Phibro Animal Health’s price movement after its last earnings report?
Phibro Animal Health reported an EPS of $0.31 in its last earnings report, beating expectations of $0.29. Following the earnings report the stock price went up 3.027%.
Which hedge fund is a major shareholder of Phibro Animal Health?
Among the largest hedge funds holding Phibro Animal Health’s share is Brandes Investment Partners LP. It holds Phibro Animal Health’s shares valued at 31M.
---
Phibro Animal Health Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Sell
Average Price Target:
$16.00 (-13.04% Downside)
$16.00 (-13.04% Downside)
Blogger Sentiment
Bullish
PAHC Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 210.9K Shares
Last Quarter.
Last Quarter.
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.02%
12-Months-Change
Fundamentals
Return on Equity
4.85%
Trailing 12-Months
Asset Growth
1.41%
Trailing 12-Months
Company Description
Phibro Animal Health
Phibro Animal Health Corp. engages in the manufacture of animal health and mineral nutrition products. It operates through the following business segments: Animal Health, Mineral Nutrition, and Performance Products. The Animal Health segment develops, manufactures, and markets antibacterial, nutritional specialty products, and vaccines. The Mineral Nutrition segment comprises of the formulations and concentrations of trace minerals such as zinc, manganese, copper, iron, and compounds. The Performance Products segment offers production of specialty ingredients for use in the personal care, automotive, industrial chemical, and chemical catalyst industries. The company was founded on May 11, 1946 and is headquartered in Teaneck, NJ.
---
PAHC Company Deck
---
PAHC Earnings Call
Q3 2024
0:00 / 0:00
---
PAHC Stock 12 Month Forecast
Average Price Target
$16.00
▼(-13.04% Downside)
Technical Analysis
Best Analysts Covering PAHC
1 Year
1 Year Success Rate
5/9 ratings generated profit
1 Year Average Return
-11.12%
reiterated a sell rating 9 days ago
Copying Balaji Prasad's trades and holding each position for 1 Year would result in 55.56% of your transactions generating a profit, with an average return of -11.12% per trade.
---